Gilead to acquire Myogen for $2.5 billion
306497
Gilead Sciences Inc. , one of the world's biggest biotechnology companies, said on Monday it agreed to acquire tiny Myogen Inc.  for $2.5 billion to gain control of its promising hypertension drugs.
82240
The knee and ankle brace maker said it agreed to be bought by the medical device maker ReAble Therapeutics for about $1.6 billion including debt.
688938
Gilead Sciences Inc. , the  world's third-biggest biotechnology company, said on Monday it  has agreed to acquire Myogen Inc.  for $2.5 billion in  a surprise transaction that gives Gilead access to Myogen's  experimental hypertension drugs.
532662
Gilead Sciences Inc. , a leading producer of HIV drugs, said yesterday it plans to acquire biotech firm Myogen Inc. for about $2.5 billion in cash, signaling a surprising expansion into treatments for pulmonary diseases.
723657
Could a jointly marketed drug lead to a joint company? Ireland&#39;s Sunday Tribune said yesterday that US pharmaceuticals company Biogen Idec (nasdaq: BIIB - news - people ) was looking to make an all-stock bid
423754
Consolidation in Europe's drugs   sector gathered steam on Thursday as Germany's Merck MRCG.DE   unveiled a $13.3-billion deal to buy Europe's top biotech firm   Serono SEO.VX, and Denmark's Nycomed won the drugs unit of   Altana ALTG.DE.
599973
Investor Carl Icahn issued a $20-per-share bid to acquire Mylan Laboratories Inc. on Friday and said &quot;at least&quot; three other potential buyers in the generic drug industry could offer more.
380782
Philips plans to buy U.S. home  medical equipment maker Respironics Inc for $5.1 billion, its  largest deal to date in an aggressive expansion in the  fast-growing healthcare sector.
508175
Smiths Group is to buy Medex, a US healthcare company, for $925m (Â£477m), including $300m of debt, in the biggest deal for the UK engineering conglomerate since the merger of Smiths and TI Group in 2000.
101536
Canada&#39;s Goldcorp said Sunday it has reached an agreement in principal to buy Wheaton River Minerals in an all-stock deal valued at about $2 billion.
654843
Financier Carl Icahn offered Friday to purchase all outstanding shares of Mylan Laboratories Inc. for $20 per share, which would value the company at approximately $5.4 billion, according to The Wall Street Journal.
760479
Australia's Healthscope Ltd.  launched a A$2.86 billion ($2.34 billion) takeover offer for larger rival Symbion Health Ltd.  on Tuesday, backed by private equity firms Ironbridge Capital and Archer Capital.
351599
NEW YORK -- Johnson &amp; Johnson will acquire Guidant Corp., one of the world&#39;s leading makers of cardiac devices, for about $25.4 billion in cash and stock.
480772
Biotech company buys itself a bigger future.
641739
NEW YORK - Goldcorp Inc. said Sunday it has agreed to buy its Canadian gold-mining competitor Wheaton River Minerals Ltd. for about $2 billion in stock.
537376
Philips will buy U.S. medical products company Respironics $5.2 billion, its biggest ever acquisition, as it expands in the fast-growing healthcare sector.
713941
GlaxoSmithKline Plc  has bought global rights to Danish biotech company Genmab's  most promising new drug, a treatment for leukemia, in a record deal worth up to $2.1 billion, the two firms said on Tuesday.